Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection.

about

Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection.

Item

http://www.wikidata.org/entity/Q55516782

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Application of Antibody-Mediat ...... ostridium difficile Infection.

@en

Application of Antibody-Mediat ...... ostridium difficile Infection.

@nl

type

Item

label

Application of Antibody-Mediat ...... ostridium difficile Infection.

@en

Application of Antibody-Mediat ...... ostridium difficile Infection.

@nl

prefLabel

Application of Antibody-Mediat ...... ostridium difficile Infection.

@en

Application of Antibody-Mediat ...... ostridium difficile Infection.

@nl

P1476

Application of Antibody-Mediat ...... lostridium difficile Infection

@en

P2093

Beatrix Förster

http://www.w3.org/2001/XMLSchema#string

Ed J Kuijper

http://www.w3.org/2001/XMLSchema#string

Monique J T Crobach

http://www.w3.org/2001/XMLSchema#string

Pui Khi Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection

Bovine milk antibodies for health

Clostridium difficile infection: new developments in epidemiology and pathogenesis

Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.

A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial.

Back to the future: recombinant polyclonal antibody therapeutics.

Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

P304

1382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMICB.2018.01382

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29988597

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

6027166

http://www.w3.org/2001/XMLSchema#string